GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract W81XWH19C018160 DEGREES PHARMACEUTICALS, INC.

Overview

Award facts

Net obligations
$5.47M
$5,473,597of $5.97M potential value
Period of performance
Sep 1, 2019 to Aug 31, 2022
Ended
Modifications
8
Latest action Jul 1, 2025
Contract type
Definitive contract
PIID W81XWH19C0181

Description of requirement

BRAND NAME ARAKODA MALARIA PROPHYLACTIC DRUG TAFENOQUINE

Dates and value

Award date
Signed on Sep 1, 2019
Potential end of performance
Aug 30, 2022
Current value
$5,473,597Base and exercised options
Potential value (if all options are exercised)
$5,971,272

Obligations by fiscal year of action

  • FY2025: -$28,966 (de-obligation)
  • FY2021: $1,138,200
  • FY2020: $2,226,863
  • FY2019: $2,137,500

Total across 4 fiscal years: $5,473,597

Net de-obligation in that fiscal year (obligations withdrawn).

The Department of Defense funded and awarded this contract. DoD contract actions are withheld at the source for about 90 days after signature, so actions signed after Aug 17, 2026 are not yet public.

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 1, 2025. View on USAspending · Recipient on SAM.gov

Recipient

LocationWASHINGTON, DC
UEIWKN5DNLTVF95
CAGE code71D06
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

For-profit organizationCorporation (not tax-exempt)Manufacturer of goods

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Defense
  2. Defense Health Agency
  3. ARMY MED RES ACQ ACTIVITY
Funded by
  1. Department of Defense
  2. Department Of The Army
  3. W4QF USA MMDA
Funded from
N/a; Field is optional prior to fy21Program activities021-2040Federal accounts (agency financial reports)

Place of performance

Place of performance
Washington, District Of Columbia County, District Of Columbia 20036-5417
Congressional district (place of performance)
DC-98As reported at the time of the action

Classification and competition

Classification

Product or service (PSC)
6505DRUGS AND BIOLOGICALS (product)

Competition

Extent competed
Not competedC
Reason not competed
Only one source-other (FAR 6.302-1 other)ONE
Solicitation procedures
Only one sourceSSS
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ
Offers received
1

Solicitation and notices

Solicitation ID
W81XWH19R0061(as reported)
Solicitation date
Jul 17, 2019

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial products/servicesA
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 1, 2019Base obligation at award: $2,137,500
Latest action
Jul 1, 2025 — Supplemental agreement (within scope)Modification P00008; obligation change -$28,966
Latest substantive action
Jul 1, 2025 — Supplemental agreement (within scope)Modification P00008; obligation change -$28,966
Actions by type
  • Base award1
  • Supplemental agreement (within scope)4
  • Option exercised3
  • Novation (contract transferred)1
9 actions recorded, Sep 1, 2019 to Jul 1, 2025; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$28,966
Latest action: change in base and all options
-$28,966

Socio-economic and policy

Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Meets requirementsA
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
IndiaIND
Place of manufacture
Mfg outside U.S. - domestic nonavailabilityJ
Sea transportation
UnknownU

Structure

Award or IDV
Award
Award type
Definitive contractD
IT commercial item category
Not IT products or servicesZ
DoD claimant program
All others not identifiable to any other procurement programC9E
Awarding agency code
9700
Awarding sub-tier code
97DH
Contracting office code
HT9425
Transactions recorded under this award key
9

Funding

Funding agency code
9700
Funding sub-tier code
2100
Funding office code
W806YH
Treasury accounts
  • 021-2020/2021-2040-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • N: Emergency P.L. 116-136
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
COVID-19 supplemental obligations
$1,158,113